MANKIND PHARMA LTD.

NSE : MANKINDBSE : 543904ISIN CODE : INE634S01028Industry : Pharmaceuticals & DrugsHouse : Private
BSE2368.25-26.4 (-1.1 %)
PREV CLOSE ( ) 2394.65
OPEN PRICE ( ) 2418.45
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 10419
TODAY'S LOW / HIGH ( )2360.00 2450.00
52 WK LOW / HIGH ( )1240.75 2488.65
NSE2369.00-29.55 (-1.23 %)
PREV CLOSE( ) 2398.55
OPEN PRICE ( ) 2398.55
BID PRICE (QTY) 2369.00 (32)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 197510
TODAY'S LOW / HIGH( ) 2360.00 2452.45
52 WK LOW / HIGH ( )1242 2490
( in Million)
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Profit Before Tax16712.3919746.0116916.1114377.358646.63
Adjustment2984.30308.07-56.591054.57872.90
Changes In working Capital1667.29-5861.21-946.33-1400.77-97.39
Cash Flow after changes in Working Capital21363.9814192.8715913.1914031.169422.14
Cash Flow from Operating Activities18133.029197.7911372.4410722.046003.72
Cash Flow from Investing Activities-10541.29-13691.44-12222.11-4391.54-4443.45
Cash Flow from Financing Activities-7397.286046.21-78.11-5269.69-1751.49
Net Cash Inflow / Outflow194.451552.55-927.781060.82-191.21
Opening Cash & Cash Equivalents2830.601273.272197.311163.901355.36
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange Fluctuations23.154.783.7536.04-0.24
Closing Cash & Cash Equivalent3048.212830.601273.282260.751163.90

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.